Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Resolution. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Novel resolution method for levodopa intermediate ensures high purity and cost efficiency. Reliable supply chain partner for pharmaceutical manufacturing needs.
Patent CN101538542B reveals a novel Pseudomonas esterase for high-purity mandelic acid. This biocatalytic route offers significant cost reduction and supply chain reliability for chiral intermediates.
Patent CN1409702A details a cost-effective asymmetric synthesis of Casodex enantiomers using citramalic acid, offering supply chain advantages over proline-based methods.
Patent CN105218428A analysis reveals high purity Apremilast synthesis route. Delivers cost reduction and supply chain reliability for global pharma manufacturing partners seeking scalable API solutions.
Patent CN101134943B reveals a novel Alcaligenes strain for >99.9% e.e. mandelic acid. Discover cost-effective biocatalytic solutions for pharmaceutical manufacturing.
Patent CN102317248A details an efficient route for (S)-3-cyclohexene-1-carboxylic acid, a key FXa inhibitor intermediate, offering significant cost and supply chain advantages.
Patent CN119285654A enables high-purity Levamisole Hydrochloride production with enhanced yield and significantly reduced costs for global pharmaceutical supply chains and procurement teams.
Patented chiral resolution process ensures high purity S-tetrahydro-2-furoic acid. Cost-effective manufacturing and reliable supply chain for global pharmaceutical partners.
Patent CN114853760B offers high purity chiral resolution for ruxolitinib. Reduces steps significantly. Reliable pharmaceutical intermediate supplier for global procurement.
Patent CN112442474B reveals a robust Fusarium oxysporum lactamase for optically pure (-) gamma-lactam production, offering superior stability and cost-effective manufacturing solutions.
Novel 5-step synthesis for L-serine offers high yield and purity. Ideal for reliable pharmaceutical intermediate supplier partnerships and cost reduction.
Patent CN105348279B reveals optimized synthesis for Aclidinium bromide intermediates ensuring high purity and scalable supply chain reliability for global pharmaceutical manufacturers.
Patent CN1309121A details efficient chiral resolution of antihistamine intermediates using DPTTA, offering high purity and scalable manufacturing for global supply chains.
Patent CN1786179A details a novel dual-enzyme biocatalytic route for S-(+)-2,2-dimethylcyclopropylcarboxamide, offering superior stereocontrol and reduced environmental impact for cilastatin synthesis.
Patent CN101659622A reveals high-purity valine splitting via DBTA. Offers cost reduction and supply chain reliability for pharmaceutical manufacturing.
Novel resolution method ensures high purity acetate salt stability for scalable API manufacturing and significant cost reduction in production.
Patent CN1373116A reveals a novel resolution method for agrochemical intermediates, offering significant cost reduction and supply chain reliability for pyrethroid manufacturers globally.
Patent CN116376872A reveals high-efficiency esterase mutants for (S)-3-cyclohexene-1-carboxylic acid, offering cost reduction and scalable biocatalysis for anticoagulant manufacturing.
Patent CN112939900A reveals a cost-effective route for Brivaracetam intermediates, eliminating chiral chromatography for scalable pharmaceutical manufacturing.
Patent CN107641130A reveals a stable D-Sulbenicillin Sodium synthesis route ensuring high optical purity and cost reduction in pharmaceutical intermediates manufacturing.